Nature Reviews Nephrology - Table of Contents alert Volume 12 Issue 2

TABLE OF CONTENTS
February 2016 Volume 12 Number 2
Impact Factor 8.542 *	In this issue Research Highlights Year in Review Reviews Also this month  Featured article: Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease Merlin C. Thomas, Mark E. Cooper & Paul Zimmet
Subscribe   Facebook   RSS   Recommend to library   Twitter
RESEARCH HIGHLIGHTS Top Glomerular disease: Addition of immunosuppression to supportive care does not STOP-IgAN Published online: 21 December 2015 p61 | doi:10.1038/nrneph.2015.209 PDF Chronic kidney disease: Role of PTH/PTHrP receptor in cachexia Published online: 21 December 2015 p62 | doi:10.1038/nrneph.2015.207 PDF IN BRIEF Genetics: Genetic links between diabetes and albuminuria | Immunosuppression: Modulation of BK polyomavirus replication | Basic research: TMEM107: a new ciliopathy transition zone gene | Progenitor cells: Promotion of nephron progenitor cell self-renewal PDF Nephrology EVENT MENA Nephrology Congress 07.05.16 dubai More science events from
YEAR IN REVIEW		Top
Podocyte biology in 2015: New insights into the mechanisms of podocyte health Jeffrey H. Miner Published online: 21 December 2015 p63 | doi:10.1038/nrneph.2015.204 Podocyte biologists can boast of some important advances in 2015. Some of the key developments include defining the transcriptional targets of the Wilms' tumour protein on a genome-wide scale, the identification of new mitochondria-centred pathways for maintaining podocyte homeostasis, and new insights into the regulation and pathogenic activation of TRPC6. Full Text | PDF
Immune regulation of kidney disease in 2015: Updates on immunosuppression in kidney disease Hans-Joachim Anders Published online: 14 December 2015 p65 | doi:10.1038/nrneph.2015.202 Numerous studies in 2015 focused on therapeutic immune modulation and immunosuppression. Trials of budenoside in patients with IgA nephropathy who are unresponsive to supportive therapy, and of low-dose IL-2 to enforce regulatory T-cell-mediated immunosuppression in autoimmune disease all produced promising results. Full Text | PDF
Stem cells and renal development in 2015: Advances in generating and maintaining nephron progenitors Ryuichi Nishinakamura Published online: 21 December 2015 p67 | doi:10.1038/nrneph.2015.203 2015 saw the publication of several important studies in the renal stem cell and developmental biology fields. Key studies provided insights into the ageing of nephron progenitors and optimal conditions to stimulate the expansion of nephron progenitors, and reported the in vitro generation of kidney organoids. Full Text | PDF
Renal fibrosis in 2015: Understanding the mechanisms of kidney fibrosis Dong Zhou & Youhua Liu Published online: 30 December 2015 p68 | doi:10.1038/nrneph.2015.215 The year 2015 has seen great progress in the renal fibrosis field, as key studies began to build a consensus on the importance of epithelial-to-mesenchymal transition, cell cycle arrest, and defective metabolism in the pathogenesis of kidney fibrosis. New findings also point to a role of developmental signalling in renal fibrogenesis. Full Text | PDF
Hypertension in 2015: Resistant hypertension: impact and evolving treatment options Lilach O. Lerman & Stephen C. Textor Published online: 14 December 2015 p70 | doi:10.1038/nrneph.2015.199 Combination therapy with optimal doses of multiple antihypertensive drugs fails to achieve blood pressure (BP) control in up to 15% of hypertensive patients. Key studies in 2015 highlighted the risks of uncontrolled hypertension and evaluated new therapeutic modalities designed to achieve satisfactory BP control in patients with treatment-resistant hypertension. Full Text | PDF
REVIEWS		Top
Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease Merlin C. Thomas, Mark E. Cooper & Paul Zimmet Published online: 10 November 2015 p73 | doi:10.1038/nrneph.2015.173 Chronic kidney disease (CKD) is a common comorbidity in patients with type 2 diabetes mellitus (T2DM). In this Review, Paul Zimmet and colleagues discuss the changing epidemiology of T2DM and the effect of these changes on the prevalence of CKD. They indicate how the decreasing prevalence of cardiovascular disease in T2DM has resulted in an increased prevalence of CKD, outline differences in the prevalence and disease burden of T2DM and CKD in various populations worldwide, and describe the financial, societal, and clinical impact of these diseases. Abstract | Full Text | PDF
Renal involvement in primary Sjögren syndrome Hélène François & Xavier Mariette Published online: 16 November 2015 p82 | doi:10.1038/nrneph.2015.174 Renal involvement in primary Sjögren syndrome (pSS) is a rare complication, but regular screening is required for early detection and prevention of progression to chronic kidney disease. In this Review, Hélène François and Xavier Mariette discuss the most frequent renal complications that can occur in pSS, namely tubulointerstitial nephritis and membranoproliferative glomerular nephritis. They outline the pathophysiology of these complications, the differential diagnoses, and current treatment options. Abstract | Full Text | PDF
The emerging role of coagulation proteases in kidney disease Thati Madhusudhan, Bryce A. Kerlin & Berend Isermann Published online: 23 November 2015 p94 | doi:10.1038/nrneph.2015.177 In the past decade considerable advances have been made in understanding the physiology and pathophysiology of coagulation proteases, their regulators and receptors in renal disease. In this Review, Berend Isermann and colleagues discuss the haemostatic and non-haemostatic functions of coagulation regulators and receptors in the kidney, the roles of coagulation proteases in acute kidney injury, chronic kidney disease and renal transplantation, and the potential for translating these insights into targeted therapies. Abstract | Full Text | PDF
Hypertension pharmacogenomics: in search of personalized treatment approaches Rhonda M. Cooper-DeHoff & Julie A. Johnson Published online: 23 November 2015 p110 | doi:10.1038/nrneph.2015.176 Hypertension is an important risk factor for cardiovascular and renal disease; however, despite the availability of several antihypertensive drug classes only about half of patients with treated hypertension achieve appropriate blood pressure control. This Review describes the potential of pharmacogenomics and other 'omics' approaches to identify genetic signals to predict an individual's response to a particular drug and enable a more personalized, or precision approach to antihypertensive treatment strategies. Abstract | Full Text | PDF
Advertisement
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events

*Journal Citation Reports, Thomson, 2014. Nature Reviews Nephrology was previously published as Nature Clinical Practice Nephrology.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department For print subscription enquiries, please contact our subscription department For other enquiries, please contact our feedback department Nature Publishing Group | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.